Citigroup’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.5K | Sell |
12,661
-6,173
| -33% | -$29K | ﹤0.01% | 3939 |
|
|
2025
Q1 | $68.7K | Sell |
18,834
-1,198
| -6% | -$4.37K | ﹤0.01% | 4015 |
|
|
2024
Q4 | $94.6K | Buy |
20,032
+1,687
| +9% | +$7.96K | ﹤0.01% | 4024 |
|
|
2024
Q3 | $171K | Buy |
18,345
+12,744
| +228% | +$119K | ﹤0.01% | 3682 |
|
|
2024
Q2 | $32.2K | Buy |
5,601
+2,216
| +65% | +$12.7K | ﹤0.01% | 4090 |
|
|
2024
Q1 | $22.7K | Buy |
3,385
+452
| +15% | +$3.03K | ﹤0.01% | 4240 |
|
|
2023
Q4 | $18.9K | Buy |
2,933
+2,388
| +438% | +$15.4K | ﹤0.01% | 4255 |
|
|
2023
Q3 | $2.73K | Sell |
545
-6,233
| -92% | -$31.2K | ﹤0.01% | 4135 |
|
|
2023
Q2 | $47.7K | Buy |
6,778
+6,301
| +1,321% | +$44.4K | ﹤0.01% | 3999 |
|
|
2023
Q1 | $2.96K | Sell |
477
-188
| -28% | -$1.17K | ﹤0.01% | 4329 |
|
|
2022
Q4 | $4.24K | Buy |
665
+360
| +118% | +$2.3K | ﹤0.01% | 4332 |
|
|
2022
Q3 | $3K | Sell |
305
-994
| -77% | -$9.78K | ﹤0.01% | 4581 |
|
|
2022
Q2 | $18K | Buy |
1,299
+476
| +58% | +$6.6K | ﹤0.01% | 4357 |
|
|
2022
Q1 | $13K | Sell |
823
-4,164
| -83% | -$65.8K | ﹤0.01% | 4622 |
|
|
2021
Q4 | $114K | Buy |
4,987
+2,756
| +124% | +$63K | ﹤0.01% | 3899 |
|
|
2021
Q3 | $31K | Buy |
2,231
+1,301
| +140% | +$18.1K | ﹤0.01% | 4256 |
|
|
2021
Q2 | $10K | Buy |
930
+453
| +95% | +$4.87K | ﹤0.01% | 4974 |
|
|
2021
Q1 | $6K | Sell |
477
-852
| -64% | -$10.7K | ﹤0.01% | 5179 |
|
|
2020
Q4 | $27K | Buy |
+1,329
| New | +$27K | ﹤0.01% | 4463 |
|